DNA-Protein Cross-link Formation Mediated by Oxanine

A NOVEL GENOTOXIC MECHANISM OF NITRIC OXIDE-INDUCED DNA DAMAGE*

Toshiaki Nakano {ddagger}, Hiroaki Terato {ddagger}, Kenjiro Asagoshi {ddagger}, Aya Masaoka {ddagger}, Miho Mukuta {ddagger}, Yoshihiko Ohyama {ddagger}, Toshinori Suzuki § , Keisuke Makino § and Hiroshi Ide {ddagger} ||

From the {ddagger}Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Higashi-Hiroshima 739-8526 and the §Institute of Advanced Energy, Kyoto University, Gokasho, Uji 611-0011, Japan

Received for publication, December 17, 2002 , and in revised form, April 22, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Chronic inflammation is a risk factor for many human cancers, and nitric oxide (NO) produced in inflamed tissues has been proposed to cause DNA damage via nitrosation or oxidation of base moieties. Thus, NO-induced DNA damage could be relevant to carcinogenesis associated with chronic inflammation. In this report, we report a novel genotoxic mechanism of NO that involves DNA-protein cross-links (DPCs) induced by oxanine (Oxa), a major NO-induced guanine lesion. When a duplex DNA containing Oxa at the site-specific position was incubated with DNA-binding proteins such as histone, high mobility group (HMG) protein, and DNA glycosylases, DPCs were formed between Oxa and protein. The rate of DPC formation with DNA glycosylases was approximately two orders of magnitude higher than that with histone and HMG protein. Analysis of the reactivity of individual amino acids to Oxa suggested that DPC formation occurred between Oxa and side chains of lysine or arginine in the protein. A HeLa cell extract also gave rise to two major DPCs when incubated with DNA-containing Oxa. These results reveal a dual aspect of Oxa as causal damage of DPC formation and as a suicide substrate of DNA repair enzymes, both of which could pose a threat to the genetic and structural integrity of DNA, hence potentially leading to carcinogenesis.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Nitric oxide (NO)1 synthesized from L-arginine by three isoforms of NO synthase mediates a variety of regulatory functions in vivo (1, 2). A high flux of NO is produced by macrophages expressing inducible NO synthase during inflammatory responses (3). Because chronic inflammation has been long recognized as a risk factor for many human cancers, it has been postulated that NO is carcinogenic by virtue of its ability to induce DNA damage (47). Although NO itself is not reactive to DNA, this molecule is converted to reactive nitrogen oxide species such as peroxynitrite (ONOO) and nitrous anhydride (N2O3). ONOO is a powerful oxidizing agent formed by the reaction with the superoxide anion () that is simultaneously excreted from macrophages. ONOO primarily oxidizes guanine to 7,8-dihydro-8-oxoguanine (8oxoG) (8), further degradation products of 8oxoG (9), and 8-nitroguanine (10, 11). 8oxoG is a potent mutagenic lesion inducing GC -> TA transversions, whereas 8-nitroguanine readily undergoes depurination to yield an abasic site, a potent lethal as well as mutagenic lesion. N2O3 is a powerful nitrosating agent that is formed by autoxidation of NO in the presence of oxygen. Nitrosation of the primary amino group of guanine, adenine, and cytosine by N2O3 induces deamination, resulting in xanthine (Xan), hypoxanthine (Hx), and uracil (U), respectively (12, 13). Nitrous acid (HNO2) also induces deamination of guanine, adenine, and cytosine by a similar mechanism (14).

We have previously identified a novel reaction product, oxanine (Oxa), that is formed by the nitrosation of guanine with NO or nitrous acid (15, 16). Oxa and Xan were formed at a molar ratio of 1:3 when 2'-deoxyguanosine or DNA was treated with NO or nitrous acid. Oxa is also formed by incubation with N-nitrosoindoles (17, 18), showing that N-nitroso compounds produced by nitrosation of secondary amines by NO or nitrous acid can mediate Oxa formation. Although Oxa can be mutagenic and cytotoxic by directly affecting DNA replication or the stability of duplex DNA (19, 20), there is another possibility: the O-acylisourea structure of Oxa is fairly reactive and can form an adduct or a DNA-protein cross-link (DPC) with nucleophilic cellular molecules (Fig. 1A). Indeed, we have recently shown in a model reaction that an Oxa-glycine adduct was formed when 2'-deoxyoxanosine and concentrated glycine were incubated in aqueous solution (21). Similarly, a diazoate derivative of 2'-deoxycytidine, a reaction intermediate formed by NO or nitrous acid (22), also reacts with lysine and its homopolymer to yield covalent adducts (23) (Fig. 1B). Interestingly, the results from several laboratories using repair-deficient Escherichia coli strains suggest that the principal DNA repair path-way for counteracting the mutagenic or cytotoxic effect of NO and nitrous acid is not base excision repair but nucleotide excision or recombination repair (14, 2428). Considering the bulky nature of DPCs and the covalent adducts potentially formed by Oxa and cytosine diazoate, it is likely that these lesions are processed by nucleotide excision or recombination repair in cells (29, 30). Consistent with this notion, it has been shown recently that UvrABC nuclease incises DPC containing a covalent T4 endonuclease adduct with a moderate efficiency (31). Thus, DPCs and covalent adducts induced by NO or nitrous acid may exert mutagenic or cytotoxic effects in the absence of appropriate repair mechanisms (14, 2428). However, except for the model reactions described above (21, 22), no studies have been performed to clarify whether DPC or adducts are formed between Oxa or cytosine diazoate in DNA and cellular components.



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 1.
Reaction schemes for adduct or cross-link formation of oxanine and cytosine diazoate. A, formation of oxanine by nitrosation of guanine and adduct or cross-link formation by the reaction with a cellular nucleophilic molecule. B, formation of cytosine diazoate by nitrosation of cytosine and adduct or cross-link formation by the reaction with a cellular nucleophilic molecule.

 

In the present study, we prepared a duplex oligonucleotide containing site-specific Oxa and examined the reactivity to proteins and polyamines. We report here that Oxa in DNA reacts with nuclear proteins such as histone, high mobility group (HMG) protein, and certain types of DNA repair enzymes (i.e. DNA glycosylases) as well as polyamines to form DPC. DPC formation is also observed in the incubation with the HeLa cell extract. The efficiencies of DPC formation with histone and DNA glycosylases differ dramatically, suggesting two distinct mechanisms of DPC formation.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Chemicals and Enzymes—2'-Deoxyoxanosine 5'-triphosphate (dOTP) was synthesized and purified as reported previously (19). Oligonucleotides with normal constituents were synthesized by the standard phosphoramidite method. A 25-mer oligonucleotide (25X) containing 8oxoG was synthesized, 5'-labeled with 32P, and annealed to the complementary strand as reported previously (32). The sequence of 25X was 5'-CATCGATAGCATCCTXCCTTCTCTC-3' (X = 8oxoG), and the duplex was designated 25X/C. Calf thymus histones H1, H2A, H2B, H3, and H4 were purchased from Roche Applied Science (Branchburg, NJ), and calf thymus HMG protein (a mixture of HMG-1 and HMG-2) was obtained from Wako (Osaka, Japan). E. coli DNA polymerase I (Klenow fragment) deficient in 3'-5' exonuclease (Pol I Kf (exo)) was obtained from New England BioLabs (Beverly, MA). DNA glycosylases, including E. coli endonuclease (Endo) III (33), Endo VIII (34), formamidopyrimidine glycosylase (Fpg) (32), and 3-methyladenine glycosylase II (AlkA) (35, 36), mouse methylpurine glycosylase (mMPG) (37), a human Endo III homolog (hNTH1) (38) and human 8-oxoguanine glycosylase (hOGG1, isoform 1a) (32, 39) were prepared as reported previously. Trypsin (Promega, Madison, WI), proteinase K (Wako, Osaka, Japan), thrombin (Amersham Biosciences, Piscataway, NJ), DNase I (Ambion, Austin, TX), and exonuclease (Exo) I (New England BioLabs, Beverly, MA) were obtained from the indicated companies.

Preparation of an Oligonucleotide Containing Oxa—Oxa was site-specifically incorporated into an oligonucleotide by a DNA polymerase reaction using dOTP. A 15-mer primer (5'-CATCGATAGCATCCT-3') was 5'-labeled with 32P and annealed to a 25-mer template (3'-GTAGCTATCGTAGGACGGAAGAGAG-5'; the underlined template position indicates where dOTP was incorporated). The template/primer (25 pmol, final concentration 62.5 nM) was incubated with dOTP (20 µM) and Pol I Kf (exo) (50 units) in 66 mM Tris-HCl (pH 7.5), 1.5 mM 2-mercaptoethanol, and 6.6 mM MgCl2 (total volume, 400 µl) at 25 °C for 5 min (first-stage reaction). Subsequently, dCTP and dTTP (final concentration, 20 µM) were added to the reaction mixture and incubation was further continued at 25 °C for 40 min (second-stage reaction). DNA was purified by phenol extraction, ethanol precipitation, and gel filtration on a Sephadex G75 column (3 ml). Under these conditions, a single residue of Oxa was incorporated immediately after the original primer terminus (i.e. opposite the underlined "C" in the template). This was confirmed by PAGE analysis of the first-stage reaction product in a separate experiment. The resulting primer terminus containing Oxa was extended to a fully replicated product by incorporation of dCTP and dTTP. dOTP is not incorporated during the second-stage reaction, because Pol I Kf (exo) inserts dOTP opposite template pyrimidines (C and T) but not purines (A and G) (19). The strand containing Oxa (5'-CATCGATAGCATCCTOCCTTCTCTC-3', O = Oxa) and the duplex were designated 25O and 25O/C, respectively. 25G containing G in place of Oxa at the same position was annealed to the complementary strand, and the resulting undamaged duplex was designated 25G/C.

Reactions of 25O/C with Proteins—25O/C (final concentration, 4 nM) was incubated with 4 µg of a histone component (H1, H2A, H2B, H3, or H4; final concentrations, 6–12 µM), a mixture of 4 µg each of all components (H1–H4; final concentrations, 6–12 µM), or 2 µg of HMG protein (final concentration, 2.7 µM) in 10 mM phosphate buffer (pH 7.4, 30 µl) at 37 °C for up to 48 h. The sample was mixed with an equal volume of SDS-loading buffer (100 mM Tris-HCl (pH 6.8), 8% SDS, 24% glycerol, 0.02% SERVA BLUE G, and 4% 2-mercaptoethanol), heated, and separated by 10% SDS-PAGE. Molecular weight markers were also electrophoresed side by side: phosphorylase (Mr = 97,400), albumin (66,267), aldolase (42,400), carbonic anhydrase (30,000), trypsin inhibitor (20,100), and lysozyme (14,400). The gel was briefly stained with Coomassie Brilliant Blue (CBB), dried, and subjected to autoradiography. The radioactivity of the gel was measured using a Fuji BAS2000 phosphorimaging analyzer. The reactions with DNA repair enzymes were performed in a similar manner. The enzymes used were DNA glycosylases from human (hNTH1 and hOGG1), mouse (mMPG), and E. coli (Endo III, Endo VIII, Fpg, and AlkA). 25O/C (final concentration, 4 nM) was incubated with 2 µg of a DNA glycosylase (final concentrations, 1.7–2.2 µM) in an appropriate buffer (30 µl) at 37 °C for up to 1 h. The composition of the incubation buffer was 50 mM Tris-HCl (pH 7.5), 1mM EDTA, 50 mM NaCl, and 1 mM DTT for hNTH1 and hOGG1; 50 mM Hepes-KOH (pH 7.8), 1 mM EDTA, 5 mM mercaptoethanol, and 10 mM KCl for mMPG; 10 mM Tris-HCl (pH 7.4), 100 mM NaCl, and 1 mM EDTA for Endo III, Endo VIII, and Fpg; and 70 mM Hepes-KOH (pH 7.8), 1 mM EDTA, and 5 mM mercaptoethanol for AlkA. Products were analyzed by SDS-PAGE as described for histone. When the reaction was performed with inactivated enzyme (or histone), proteins (hOGG1, AlkA, Endo VIII, and histone mixture) were heat-denatured at 80 °C for 10 min prior to incubation. The heat treatment of hOGG1, AlkA, and histone did not result in significant changes in protein concentrations as judged from SDS-PAGE analysis. However, the concentration of Endo VIII was decreased to one-third of that before heat treatment probably due to aggregation of the protein. Thus, the concentration of Endo VIII was increased (3-fold) in the reaction with inactivated Endo VIII (see also "Results" for Fpg).

Protease and DNase Treatment of DPCs—25O/C and protein (histone H2B, Fpg, or Endo VIII) were incubated as described above. After incubation, an aliquot (2.5 µl) of the reaction mixture was further treated with trypsin, proteinase K, thrombin, DNase I, or Exo I in a buffer recommended by the suppliers (final volume, 10 µl) at 37 °C for 10 min to 1 h. Further details of the experiments are described in the figure. Products were analyzed by SDS-PAGE.

Reactions with HeLa Cell Extracts—The nuclear cell extract was prepared from confluent HeLa cells. All procedures were performed at 4 °C or on ice. The harvested cells were suspended in 5 volumes of 10 mM Hepes-KOH (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), and 0.5 mM DTT, and cells were collected by centrifugation at 1,800 x g for 10 min. The cell pellet was suspended in 3 volumes of hypotonic buffer (20 mM Hepes-KOH (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.2 mM PMSF, and 0.5 mM DTT). The cells were disrupted with a Dounce homogenizer (20 strokes). The sample was centrifuged (3,300 x g for 15 min), and the supernatant was discarded. The precipitate containing cell nuclei was mixed with a half volume of low salt buffer (20 mM Hepes-KOH (pH 7.9), 1.5 mM MgCl2, 20 mM KCl, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT, and 25% glycerol) followed by a half volume of hypertonic buffer (20 mM Hepes-KOH (pH 7.9), 1.5 mM MgCl2, 1.2 M KCl, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT, and 25% glycerol) and kept standing for 30 min. The sample was centrifuged at 25,000 x g for 30 min, and the supernatant was dialyzed (Mr cut-off = 3,000) against 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.2 mM PMSF, and 0.5 mM DTT for 5 h. The extract was stored as aliquots at –80 °C. The protein concentration was determined with a BCA protein assay kit (Pierce, Rockford, IL). 25O/C (final concentration, 4 nM) was incubated with the cell extract (20 µg as protein) in 10 mM Tris-HCl (pH 7.4), 0–100 mM KCl, and 1 mM EDTA (total volume, 15 µl) at 37 °C for 1 h. The products were analyzed as described for histone. The reaction with the heat-treated cell extract (80 °C for 10 min) was performed in a similar manner.

For the assays with anti-hOGG1 antibody-treated cell extracts, the cell extract (20 µg as protein) was incubated with serially diluted monoclonal anti-hOGG1 antibody (1, 1/10, or 1/100 dilution: 2.5 µl) at 4 °C for 30 min. The monoclonal antibody raised against a whole hOGG1 (isoform 1a) protein was a gift from Sankar Mitra, University of Texas Medical Branch, Galveston, TX. The cell extract pretreated with the antibody was incubated with 25O/C as described above, and DPC was analyzed by SDS-PAGE. In parallel experiments, the antibody-treated cell extract (8 µg as protein) was incubated with 25X/C (final concentration, 2 nM) containing 8oxoG in 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 50 mM NaCl, and 1 mM DTT (total volume, 10 µl) at 37 °Cfor1h. The sample was mixed with 1 M NaOH (final concentration, 0.1 M), heated at 70 °C for 10 min to completely cleave abasic sites, and neutralized with 1 M acetic acid. Products were mixed with a formamide gel loading buffer (0.1% xylene cyanol, 0.1% bromphenol blue, 20 mM EDTA, and 95% formamide), heated, and analyzed by 16% denaturing PAGE containing 8 M urea. The radioactivity of the gel was analyzed as described for SDS-PAGE.

Reactions of 25O/C with Amino Acids and Amines—25O/C (final concentration, 2 nM) was incubated with an amino acid or an acetylated amino acid (final concentration, 1 mM) (Sigma, St. Louis, MO) in 10 mM Tris-HCl (pH 7.4) and 1 mM EDTA (total, 40 µl) at 37 °C for up to 48 h. After incubation, DNA was recovered by ethanol precipitation. The sample was mixed with formamide gel loading buffer, heated, and separated by 16% denaturing PAGE. The radioactivity of the gel was analyzed as described above. The reactions with monoamines (propylamine and dipropylamine) and polyamines (spermidine, spermine, and putrescine) were performed in a similar manner.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
DPC Formation with Histone and HMG Protein—25O/C was incubated with individual histone components (molar ratio of 25O/C:histone = 1:1,000–3,000) for 12–36 h, and the products were analyzed by SDS-PAGE. Fig. 2A shows the SDS-PAGE data for the sample after 36 h of incubation. All histone components (H1, H2A, H2B, H3, and H4) reacted with 25O/C to form DPCs so that new bands other than free DNA were observed in autoradiogram (Fig. 2A, right panel). The gel mobility of DPCs was lower than that of the corresponding free proteins as well as free DNA (Fig. 2A). The apparent Mr values of free histones and their DPCs were determined from the gel mobility of free histones (CBB-stained bands) and that of DPCs (autoradiogram) (Fig. 3A). The differences in the Mr between free histone components and the corresponding DPCs were 7,900–11,000, which corresponded to the approximate size of single-stranded 25O (Mr = 8,100). Thus, DPC comprised a histone component and 25O/C at a ratio of 1:1 before denaturation of the complex. DPC was not formed when the reaction was performed with 25G/C containing G in place of Oxa at the same site (data not shown), indicating that the cross-link reaction was specific for Oxa. Because the preparations of histones H2B and H3 contained histones H4 and H1/H2A as contaminants, respectively (Fig. 2A, left panel, marked bands), DPCs due to the contaminants also appeared as additional bands in the autoradiogram (Fig. 2A, right panel, marked bands). The apparent rate constant of cross-link formation of Oxa (kapp) was calculated from the hourly yield of DPC ([Cross-link product]in Table I) and the concentration of histone ([Protein (amine)] in Table I) by applying second order reaction kinetics, where kapp = [Cross-link product]/([25O/C] x [Protein (amine)]). The variation in kapp for the histone components was at most 3-fold (lowest for H1 and highest for H4, Table I). 25O/C was also incubated with a mixture of all histone components under similar conditions. Each component formed DPC (Fig. 2B), but the total amount of DPC formed with the histone mixture was significantly lower (by about 5-fold) than the simple summation of DPC formed from individual reactions (e.g. compare Fig. 2A, right panel (all 36 h reactions), with Fig. 2B, right panel, at the 36-h reaction). Histones H2A and H2B form a stable dimer (H2A/H2B), and H3 and H4 form a stable tetramer [(H3/H4)2] in the absence of DNA (40, 41). It is possible that the association between histone components might have masked reactive sites in the proteins or reduced the effective concentration of histones available for the reaction. HMG protein also reacted with 25O/C to form DPC (Fig. 2C). The reaction conditions of HMG protein were similar to those for histone (molar ratio of 25O/C:HMG = 1:675 and incubation time = 12–36 h). The DPC contained HMG protein and 25O/C at a ratio of 1:1 as judged from the increase in the apparent Mr (Fig. 3A). The value of kapp with HMG protein was comparable to those of histone components (Table I).



View larger version (39K):
[in this window]
[in a new window]
 
FIG. 2.
Cross-link formation between Oxa and histone or HMG protein. A, 25O/C containing Oxa (25O was 5'-labeled with 32P) was incubated with the indicated histone components (H1, H2A, H2B, H3, and H4) at 37 °C for 36 h. Products were separated by SDS-PAGE. Left panel, SDS-gel stained with CBB. The band positions of the Mr markers are indicated on the left. The bands marked with dots correspond to contaminated proteins (see text for details). Note that histone components (and HMG protein in C) did not exhibit the gel mobilities expected from their Mr values due to the high basicity. Right panel, autoradiogram of the SDS-gel. The bands of free DNA and cross-linked products are indicated. The bands marked with dots were cross-linked products arising from contaminated protein. B, 25O/C was similarly incubated with a mixture of histone components (H1–H4) at 37 °C for up to 36 h. Products were separated by SDS-PAGE. Left panel, CBB-stained SDS-gel for the sample with an incubation time of 36 h. The bands of histone components (H1–H4) are indicated. Right panel, autoradiogram of the SDS-gel for the samples with an incubation time of 0, 12, 24, or 36 h. C, same as B except that HMG protein was used instead of a histone mixture.

 


View larger version (19K):
[in this window]
[in a new window]
 
FIG. 3.
Determination of apparent Mr values of free proteins and their DPCs. A, the indicated histone components or HMG protein were incubated with 25O/C, and products were separated by SDS-PAGE as shown in Fig. 2. The gel mobilities of free proteins and their DPCs were determined from the CBB-stained bands and autoradiogram, respectively. The mobilities of free histones and DPCs are plotted on the Mr calibration curve obtained with Mr standards (phosphorylase (Mr = 97,400), albumin (66,267), aldolase (42,400), carbonic anhydrase (30,000), trypsin inhibitor (20,100), and lysozyme (14,400)). Symbols: {circ}, free histone, HMG protein, and single-stranded 25O; {Delta}, DPCs formed with 25O (also indicated by asterisks); and •, Mr standards. B, the gel mobilities of indicated DNA glycosylases and their DPCs are plotted on the Mr calibration curve obtained with Mr standards. Symbols: {circ}, free DNA glycosylases and single-stranded 25O; {Delta}, DPCs formed with 25O (also indicated by asterisks); and •, Mr standards.

 

View this table:
[in this window]
[in a new window]
 
TABLE I
Apparent rate constants of cross-link formation of oxanine (kapp) with proteins and amine derivatives

 

DPC Formation with DNA Glycosylases—25O/C was incubated with DNA glycosylases from E. coli (Endo III, Endo VIII, Fpg, and AlkA) and mammal (hNTH1, hOGG1, and mMPG) for up to 1 h. The molar ratio of 25O/C:DNA glycosylase was 1:425–550 in the experiments. Unlike histone and HMG protein, Endo VIII, Fpg, AlkA, and hOGG1 formed DPCs very rapidly (Fig. 4). The DPC band was observed after 10 min of incubation. In contrast, Endo III, hNTH1, and mMPG did not form DPC after 1 h of incubation. With the cross-linked enzymes, the increase in the apparent Mr of DPC relative to free protein was 9000–9800 (Fig. 3A), indicating that DPC was a 1:1 complex of enzyme and 25O/C. For Endo VIII, minor DPC species were observed just below the major DPC in the autoradiogram. Because the Endo VIII preparation used here exhibited a CBB-stained single band in protein analysis by SDS-PAGE, the minor DPCs might be due to nicked 25O, albeit inconclusive. Endo VIII exhibited a very weak incising activity for 25O/C (data not shown), which became evident when a large amount of Endo VIII was used as in this experiment. The kapp values for the DNA glycosylases (Endo VIII, Fpg, AlkA, and hOGG1) were two orders of magnitude greater than those for the histone components and HMG protein (Table I), implying distinct mechanisms of DPC formation for the DNA glycosylases and histone/HMG. When the DNA glycosylases (Endo VIII, AlkA, and hOGG1) were inactivated by heat (80 °C for 10 min) prior to the reaction, DPC was not formed after 1 h of incubation (Fig. 5). Conversely, similar heat treatment of histone did not affect DPC formation (Fig. 5). These results indicate that catalytically competent (or properly folded) protein is essential for the rapid DPC formation of DNA glycosylases, whereas proper folding is not essential for the slow DPC formation of histone. Consistent with a previous report (42), Fpg became completely insoluble due to aggregation when treated with heat. Thus, the reaction with heat-denatured Fpg was not possible.



View larger version (53K):
[in this window]
[in a new window]
 
FIG. 4.
Differential cross-linking capacities of DNA glycosylases to Oxa. The indicated enzymes were incubated with 25O/C containing Oxa (25O was 5'-labeled with 32P) at 37 °C for 0, 10, 30, 45, or 60 min (or 0, 30, or 60 min for mMPG), and products were separated by SDS-PAGE. Autoradiograms of the SDS-gels are shown, and the bands of free DNA and cross-linked products are indicated.

 


View larger version (35K):
[in this window]
[in a new window]
 
FIG. 5.
Effects of heat denaturation on the cross-linking ability of DNA glycosylases and histone. Native (indicated by –) and heat-denatured (indicated by +) DNA glycosylases (Endo VIII, AlkA, and hOGG1(1a)) or histone (a mixture of H1–H4) were incubated with 25O/C containing Oxa (25O was 5'-labeled with 32P) at 37 °C for 1 h (DNA glycosylases) or 36 h (histone). Products were separated by SDS-PAGE. Autoradiograms of the SDS-gels are shown, and the bands of free DNA and cross-linked products are indicated.

 

Sensitivity of DPCs to Proteases and DNases—To confirm the nature of DPC as a DNA-protein complex, the reaction mixture after incubation of 25/O with protein (histone H2B, Fpg, or Endo VIII) was treated with proteases or DNases. Fig. 6 shows typical results of product analysis by SDS-PAGE. The DPC formed with histone H2B was broken down by trypsin and proteinase K (Fig. 6A), indicating proteolytic cleavage of the associated protein. Conversely, the DPC was resistant to digestion with thrombin that has no recognition sites in histone H2B (X1X2P(R/K)X3X4, X1 and X2 = hydrophobic amino acids and X3 and X4 = non-acidic amino acids) (Fig. 6A). Similarly, the DPC was degraded by DNase I and Exo I (Fig. 6B), showing hydrolysis of the associated DNA. The free DNA was also digested by the enzymes. The DPCs containing Fpg and Endo VIII were also sensitive to digestion with proteases (trypsin and proteinase K (but not to thrombin)) and DNases (DNase I and Exo I) (data not shown). These results clearly demonstrated that observed DPCs were complexes of DNA and protein.



View larger version (68K):
[in this window]
[in a new window]
 
FIG. 6.
Digestion of DPC containing histone H2B with proteases and DNases. 25O/C and histone H2B were incubated as described in Fig. 2, and an aliquot of the reaction mixture was further treated with proteases (A) or DNases (B). Products were analyzed by SDS-PAGE. The left-most and second lanes for each enzyme show free DNA and a reaction mixture without enzyme digestion, respectively. In A, the sample was digested with trypsin or proteinase K (both 0.0001, 0.001, 0.01, and 0.1 unit from left to right lanes) for 10 min, or with thrombin (0.01, 0.1, 1, and 10 units) for 1 h. In B, the sample was digested with DNase I (0.1, 0.2, 0.5, and 1 unit from left to right lanes) or Exo I (1, 2, 5, and 10 units) for 1 h.

 

Analysis of DPCs Produced by Cell Extracts—Nuclear extracts from HeLa cells were incubated with 25O/C at 37 °C for 1 h. SDS-PAGE analysis of the products revealed two major DPCs (designated as DPC1 and DPC2) (Fig. 7A, lane 2). The formation of DPC1 and DPC2 was rapid, as indicated by their bands appearing after 1 h of incubation. DPC1 and DPC2 were preferentially formed in the presence of 50 and 100 mM KCl compared with in 0 mM KCl (data not shown). The apparent Mr values of DPC1 and DPC2 were 49,000 and 77,000, respectively, suggesting that the original Mr values of cross-linked proteins were ~41,000 and 69,000, respectively. The gel mobility of DPC1 was slightly lower than that of DPC formed between hOGG1 (isoform 1a) and 25O (Fig. 7A, lane 8, DPC-hOGG1(1a)). As for purified DNA glycosylases (Fig. 5), the formation of DPC1 and DPC2 was sensitive to heat treatment so that virtually no DPC formation was observed when the cell extract was treated at 80 °C for 10 min prior to the reaction (Fig. 7A, lane 3). When the cell extract was incubated with single-stranded 25O, DPC formation was not observed either (data not shown). Thus, native protein and duplex DNA were indispensable for DPC formation with the cell extract.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 7.
Analysis of cross-link products formed between Oxa and HeLa cell extracts. A, 25O/C containing Oxa (25O was 5'-labeled with 32P) was incubated with the cell extract (lanes 2 and 4), heat-treated cell extract (lane 3), and anti-hOGG1 antibody-treated cell extract (lanes 5–7) at 37 °C for 1 h. Products were separated by SDS-PAGE. The autoradiogram of the SDS-gel is shown. Lane 8 shows a cross-link product (DPC-hOGG1(1a)) prepared by the reaction of 25O/C with hOGG1 (isoform 1a). The amount of antibody added to the cell extract was 2.5 µl, but serially diluted as follows: lane 5, 1/100 dilution; lane 6, 1/10 dilution; and lane 7, no dilution. The bands of free DNA, two major cross-link products formed by the cell extract (DPC1 and DPC2), and DPC-hOGG1(1a) are indicated. B, 25X/C containing 8oxoG (25X was 5'-labeled with 32P) was incubated with the cell extract (lane 2) or anti-hOGG1 antibody-treated cell extract (lanes 3–5) at 37 °C for 1 h. The cell extract was pretreated with the antibody as described in A, and the products were separated by 16% denaturing PAGE. The autoradiogram of the gel is shown. C, the amount of DPC1 formed with 25O/C (A) and that of the nicked product formed with 25X/C (B) are plotted against the amount of anti-hOGG1 antibody used for treatment of the cell extract. The data are standardized to those without antibody treatment. Open bar, DPC1 formed with 25O/C; closed bar, nicked product formed with 25X/C.

 

The Mr of a protein involved in DPC1 was ~41,000, which was slightly larger than hOGG1 (isoform 1a, Mr = 38,782) used as a marker. However, hOGG1 has several alternative splicing isoforms, some of which (isoforms 1c (predicted Mr = 45,760), 2a (47,236), 2b (39,729), and 2d (40,094)) are larger than isoform 1a (38, 782) (43, 44). Thus, a large isoform of hOGG1 could give rise to DPC1. To clarify whether this was the case, the cell extract was treated with anti-hOGG1 antibody to deplete hOGG1. When 25X/C containing 8oxoG was incubated with the antibody-treated cell extract, incision activity for 25X in the extract, the hallmark of hOGG1 activity, was inhibited (Fig. 7, B and C). The extent of the inhibition was dependent on the amount of the antibody. In contrast, depletion of cellular hOGG1 by the antibody had no effect on the formation of DPC1 (and DPC2) (Fig. 7, A (lanes 5–7) and C), indicating that hOGG1 was not involved in the formation of the observed DPCs.

Comparison of the Reactivities of Amino Acids and Amines to Oxa—To elucidate the amino acid residue involved in DPC formation in proteins, 20 free amino acids were incubated with 25O/C at 37 °C for 48 h (molar ratio of 25O/C:amino acid = 1:4 x 105), and products were analyzed by denaturing PAGE. Free Cys, Lys, Arg, and His formed adducts with Oxa in 25O/C (Fig. 8A). 25O containing the amino acid adduct migrated slower than intact 25O in denaturing PAGE. The adduct formation occurred with 25O/C but not 25G/C containing G in place of Oxa at the same position (Fig. 8B). Because the free N{alpha}-amino group of Cys, Lys, Arg, and His is not available in the protein for the reaction due to amide bond formation, the reaction with N{alpha}-acetylated derivatives of the amino acids were further examined. PAGE analysis revealed that the N{alpha}-acetylated derivatives of Lys and Arg but not those of Cys and His reacted with 25O/C (data not shown). These results indicate that the side chains of Lys (–(CH2)4NH2) and Arg (–(CH2)3NH(=NH)NH2) in protein are possibly involved in DPC formation. The reactivity of the side chains of Lys and Arg for 25O/C was comparable when assessed using N{alpha}-acetylated derivatives of Lys and Arg (Fig. 9).



View larger version (41K):
[in this window]
[in a new window]
 
FIG. 8.
Adduct formation of Oxa with amine derivatives. A, 25O/C containing Oxa (25O was 5'-labeled with 32P) was incubated with the indicated free amino acids (all 1 mM) at 37 °C for 48 h. Products were separated by 16% denaturing PAGE. The autoradiogram of the gel is shown, and the bands of free DNA and Oxa-amino acid adducts are indicated. B, 25O/C and 25G/C (25O and 25X were 5'-labeled with 32P) containing Oxa and G, respectively, at the same position were incubated with free amino acid (His, Arg, Lys, and Cys) or polyamine (spermine and spermidine) (all 1 mM) at 37 °C for 48 h (amino acids) or 20 min (polyamines). Products were separated by 16% denaturing PAGE. The autoradiogram of the gel is shown.

 


View larger version (30K):
[in this window]
[in a new window]
 
FIG. 9.
Comparison of the reactivity of Lys, Arg, and polyamines to Oxa. 25O/C was incubated with Lys, N{alpha}-acetylated Lys (N{alpha}-Ac), and N{epsilon}-acetylated Lys (N{epsilon}-Ac) (A); Arg and N{epsilon}-acetylated Arg (N{alpha}-Ac) (B); and spermine and spermidine (C) at 37 °C for the indicated time. The concentrations of the amino acids and polyamines were all 1 mM. The percent fraction of adducted Oxa in 25O was determined by PAGE analysis and is plotted against incubation time.

 

Because a subgroup of free amino acids formed adducts with 25O/C, the reaction with monoamines and biologically relevant polyamines was examined further. The tested monoamines were propylamine (NH2CH2CH2CH3) and dipropylamine (NH(CH2CH2CH3)2), and polyamines were spermidine (NH2(CH2)3NH(CH2)4NH2), spermine (NH2(CH2)3NH(CH2)4NH(CH2)3NH2), and putrescine (NH2(CH2)4NH2). The ratio of amine:25O/G for the reaction was the same as that for amino acids (molar ratio of 25O/C:amine = 1:4 x 105). Spermidine and spermine reacted with 25O/C very rapidly to form adducts (Fig. 8B), with most of the 25O/C converted to the adduct after 15 min of incubation (Fig. 9). The kapp values of spermidine and spermine were 800-fold higher than those of N{alpha}-acetylated derivatives of Lys and Arg (Table I). Although putrescine also formed an adduct, the reactivity for 25O/C was comparable to those of N{alpha}-acetylated derivatives of Lys and Arg (data not shown). The monoamines (propylamine and dipropylamine) did not form adducts even after 48 h of incubation. Accordingly, the reactivity of the amines for Oxa varied markedly and appeared to be dependent on the number of amino groups (or positively charged groups) in the molecule (polyamine > diamine >> monoamine (reaction not observed)). With the exception of Cys, this was also the case for free amino acids. Lys, Arg, and His bearing a positively charged side chain reacted with Oxa but other amino acids did not under the present conditions (see above). It is tempting to speculate that electrostatic interactions between the negatively charged DNA backbone and the positive charge in the polyamines or amino acid side chains facilitate the association of DNA and nucleophilic molecules to form adducts.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
NO and nitrous acid induce deamination of C and A, resulting in U and Hx, respectively. To avoid genotoxic effects of the aberrant bases, U and Hx are removed from DNA by uracil-DNA glycosylase and methylpurine-DNA glycosylase, respectively, both in eukaryotic and prokaryotic cells (45, 46). NO and nitrous acid also induce deamination of G, yielding Xan and Oxa. However, the cellular repair mechanism of Xan and Oxa has been clarified only partially (47). Although unrepaired Xan and Oxa lesions can exert genotoxic effects by directly affecting DNA replication (19, 48, 49) or reducing the stability of duplex DNA (20), in this study we have demonstrated a novel genotoxic mechanism of Oxa that involves DPC formation. Oxa in DNA reacted with nuclear proteins such as histone, HMG protein, and DNA glycosylases to form DPCs (Figs. 2 and 4). The nature of the DPCs as complexes of DNA and protein was further confirmed by the protease and DNase treatment (Fig. 6). Small amine molecules such as spermidine, spermine, and a subgroup of amino acids also reacted with Oxa to form adducts (Fig. 8). The formation of DPCs (DPC1 and DPC2) was also observed when 25O/C containing Oxa was incubated with the nuclear extract from HeLa cells (Fig. 7A). Although purified hOGG1 reacted with 25O/C (Fig. 4), DPC1 and DPC2 formed with the HeLa cell extract did not contain the possible isoforms of hOGG1. However, formation of DPC1 and DPC2 was rapid and sensitive to heat treatment and required duplex DNA. Thus, like DNA glycosylases, the proteins involved in DPC1 and DPC2 appear to interact with Oxa in a damage-specific manner.

DPCs are induced by a number of chemical (e.g. aldehydes, nitrous acid, and metal compounds such as arsenite, nickel, and chromate) and physical agents (e.g. UV light and ionizing radiation) (Refs. 50 and 51 and references cited therein). These agents are mutagenic, and many of them are suspected or known carcinogens, although the mechanistic link between DPCs and carcinogenesis has not been fully elucidated. However, it can be readily inferred from their bulky nature that DPCs formed by NO (in this study) and those mentioned above raise a barrier to progression of a DNA replication fork or reduce the fidelity of DNA synthesis and consequently lead to chromosomal aberrations (52). Consistent with this, only those aldehydes with a specific DPC-forming ability disrupt SV40 replication (53). Together with NO and ONOO, hypochlorous acid (HOCl) is an important component of host defenses against infection and inflammatory responses (54). HOCl formed by the myeloperoxidase-H2O2-Cl system of phagocytes generates DPCs between single-stranded DNA-binding protein and a single-stranded oligonucleotide (dT40) (55). DPCs are also formed in E. coli exposed to HOCl (55). Accordingly, DPCs formed by NO and HOCl may help elucidate the molecular mechanism of genotoxic and cytotoxic effects in inflammatory responses.

The comparison of kapp values has revealed that a subset of DNA glycosylases (hOGG1, Fpg, AlkA, and Endo VIII) reacts with Oxa much more rapidly than histone and HMG protein. The content of Arg and Lys potentially involved in DPC formation differs depending on the proteins, but the difference appears too small to fully account for the large difference in kapp for the DNA glycosylases and histone/HMG protein (Table I). Also, native (or active) structures were essential for rapid DPC formation with the DNA glycosylases, whereas the rate of DPC formation with histone was independent of heat denaturation (Fig. 5). These results strongly suggest that slow DPC formation with histone and HMG protein occurs via nonspecific DNA-protein interactions, whereas fast DPC formation with the DNA glycosylases occurs via damage-specific interactions. hOGG1, Fpg, AlkA, and Endo VIII use a base-flipping mechanism to accommodate the aberrant base (5659). Although the excision activity of the enzymes for Oxa is virtually negligible (data not shown), Oxa may be accommodated in the active site pocket in a manner similar to physiological substrates, forming a covalent amide bond with a proximal amino acid such as Arg or Lys. hOGG1, Fpg, and AlkA accept purine lesions as favored damage (5658), whereas hNTH1 and Endo III accept pyrimidine lesions (33, 38). Recently, it has been reported that Endo VIII recognizes not only pyrimidine lesions but also some purine lesions (34, 60). Accordingly, with an exception of mMPG that recognizes methylated purines and Hx (61), DPC formation for DNA glycosylases parallels the substrate specificity (or the architecture of the enzyme active site pocket). mMPG might not have Arg or Lys in the active site pocket or these amino acids may be improperly located for cross-link formation with Oxa, albeit speculative.

It should be noted that, although the value of kapp is useful for elucidating the mechanistic aspect of DPC formation, this parameter does not necessarily correlate with the biological significance of a particular type of DPC. Histone and HMG protein (a major non-histone protein) are abundant in eukaryotic cells and are associated with DNA to maintain chromatin structure or to coordinate transcription. A high abundance of the proteins and the constant association with DNA may over-whelm the low reactivity to Oxa and, consequently, result in a significant amount of DPCs. Alternatively, constant damage surveillance of DNA glycosylases and a high reactivity to Oxa may compensate for the low abundance of the protein in cells, leading to a significant amount of DPCs. Thus, evaluation of the biological significance of the different types of DPCs (and amine adducts) must await quantitation of individual types of DPCs and amine adducts in cells exposed to NO or nitrous acid.

Analysis of the reaction with amino acids and their acetylated derivatives suggested the formation of a covalent amide bond between the side chain of Arg or Lys in protein and O-acylurea in Oxa (Fig. 9). Recently, it has been shown that a covalent amide bond is formed between 2-deoxyribonolactone in DNA and catalytically important amino acid residues in DNA glycosylases (62, 63) and DNA polymerase {beta} (64, 65). 2-Deoxyribonolactone is a type of abasic lesion formed by oxidation of a natural abasic site. Although Oxa and 2-deoxyribonolactone are base and sugar lesions, respectively, they have a lactone structure in common that is prone to react with nucleophilic molecules. cis-Platinum, which is known to form DPC and is used as a anticancer drug, also induces cross-links between DNA and UvrA/UvrB proteins involved in nucleotide excision repair (66). Thus, irreversible inhibition of repair enzymes by covalent trapping has a dual biological effect: DPC formation in general and suicide of DNA repair enzymes in particular. Both could pose a threat to the genetic and structural integrity of DNA, hence initiating a carcinogenic process.


    FOOTNOTES
 
* This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to H. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Present address: Dept. of Biological Pharmacy, School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Okayama 703-8516, Japan. Back

|| To whom correspondence should be addressed. Tel./Fax: 81-824-24-7457; E-mail: ideh{at}hiroshima-u.ac.jp.

1 The abbreviations used are: NO, nitric oxide; Oxa, oxanine; 8oxoG, 7,8-dihydro-8-oxoguanine; Xan, xanthine; Hx, hypoxanthine; dOTP, 2'-deoxyoxanosine 5'-triphosphate; DPC, DNA-protein cross-link; DPC1 and DPC2, major DPCs formed with HeLa cell extracts; HMG, high mobility group; Endo, endonuclease; Exo, exonuclease; Fpg, formamidopyrimidine glycosylase; AlkA, 3-methyladenine glycosylase II; mMPG, mouse methylpurine glycosylase; hNTH1, a human Endo III homolog; hOGG1, human 8-oxoguanine glycosylase; CBB, Coomassie Brilliant Blue; Pol, polymerase; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl fluoride. Back


    ACKNOWLEDGMENTS
 
We thank R. Roy (American Health Foundation, Valhalla, New York), S. Ikeda (Okayama University of Science, Okayama, Japan), and S. Mitra (University of Texas Medical Branch, Galveston, Texas) for generous gifts of mMPG protein, an E. coli strain carrying pGEX-hNTHmet1 for purification of hNTH1, and anti-hOGG1 antibody, respectively.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Marletta, M. A. (1994) Cell 78, 927–930[Medline] [Order article via Infotrieve]
  2. Wang, Y., and Marsden, P. A. (1995) Adv. Pharmacol. 34, 71–90[Medline] [Order article via Infotrieve]
  3. MacMicking, J., Xie, Q. W., and Nathan, C. (1997) Annu. Rev. Immunol. 15, 323–350[CrossRef][Medline] [Order article via Infotrieve]
  4. Ohshima, H., and Bartsch, H. (1994) Mutat. Res. 305, 253–264[Medline] [Order article via Infotrieve]
  5. Tamir, S., and Tannenbaum, S. R. (1996) Biochim. Biophys. Acta 1288, 31–36
  6. Wink, D. A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M. W., and Mitchell, J. B. (1998) Carcinogenesis 19, 711–721[Abstract]
  7. Felley-Bosco, E. (1998) Cancer Metastasis Rev. 17, 25–37[CrossRef][Medline] [Order article via Infotrieve]
  8. Kennedy, L. J., Moore, K., Jr., Caulfield, J. L., Tannenbaum, S. R., and Dedon, P. C. (1997) Chem. Res. Toxicol. 10, 386–392[CrossRef][Medline] [Order article via Infotrieve]
  9. Tretyakova, N. Y., Niles, J. C., Burney, S., Wishnok, J. S., and Tannenbaum, S. R. (1999) Chem. Res. Toxicol. 12, 459–466[CrossRef][Medline] [Order article via Infotrieve]
  10. Yermilov, V., Rubio, J., and Ohshima, H. (1995) FEBS Lett. 376, 207–210[CrossRef][Medline] [Order article via Infotrieve]
  11. Yermilov, V., Rubio, J., Becchi, M., Friesen, M. D., Pignatelli, B., and Ohshima, H. (1995) Carcinogenesis 16, 2045–2050[Abstract]
  12. Wink, D. A., Kasprzak, K., S., Maragos, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., and Keefer, L. K. (1991) Science 254, 1001–1003[Medline] [Order article via Infotrieve]
  13. Caulfield, J. L., Wishnok, J. S., and Tannenbaum, S. R. (1998) J. Biol. Chem. 273, 12689–12695[Abstract/Free Full Text]
  14. Hartman, Z., Henrikson, E. N., Hartman, P. E., and Cebula, T. A. (1994) Environ. Mol. Mutagen. 24, 168–175[Medline] [Order article via Infotrieve]
  15. Suzuki, T., Yamaoka, R., Nishi, M., Ide, H., and Makino, K. (1996) J. Am. Chem. Soc. 118, 2515–2516[CrossRef]
  16. Suzuki, T., Ide, H., Yamada, M., Endo, N., Kanaori, K., Tajima, K., Morii, T., and Makino, K. (2000) Nucleic Acids Res. 28, 544–551[Abstract/Free Full Text]
  17. Lucas, L. T., Gatehouse, D., and Shuker, D. E. (1999) J. Biol. Chem. 274, 18319–18326[Abstract/Free Full Text]
  18. Lucas, L. T., Gatehouse, D., Jones, G. D., and Shuker, D. E. (2001) Chem. Res. Toxicol. 14, 158–164[CrossRef][Medline] [Order article via Infotrieve]
  19. Suzuki, T., Yoshida, M., Yamada, M., Ide, H., Kobayashi, M., Kanaori, K., Tajima, K., and Makino, K. (1998) Biochemistry 37, 11592–11598[CrossRef][Medline] [Order article via Infotrieve]
  20. Suzuki, T., Matsumura, Y., Ide, H., Kanaori, K., Tajima, K., and Makino, K. (1997) Biochemistry 36, 8013–8019[CrossRef][Medline] [Order article via Infotrieve]
  21. Suzuki, T., Yamada, M., Ide, H., Kanaori, K., Tajima, K., Morii, T., and Makino, K. (2000) Chem. Res. Toxicol. 13, 227–230[CrossRef][Medline] [Order article via Infotrieve]
  22. Suzuki, T., Nakamura, T., Yamada, M., Ide, H., Kanaori, K., Tajima, K., Morii, T., and Makino, K. (1999) Biochemistry 38, 7151–7158[CrossRef][Medline] [Order article via Infotrieve]
  23. Suzuki, T., Yamada, M., Nakamura, T., Ide, H., Kanaori, K., Tajima, K., Morii, T., and Makino, K. (2000) Chem. Res. Toxicol. 13, 1223–1227[CrossRef][Medline] [Order article via Infotrieve]
  24. Routledge, M. N. (2000) Mutat. Res. 450, 95–105[Medline] [Order article via Infotrieve]
  25. Tamir, S., Burney, S., and Tannenbaum, S. R. (1996) Chem. Res. Toxicol. 9, 821–827[CrossRef][Medline] [Order article via Infotrieve]
  26. Spek, E. J., Wright, T. L., Stitt, M. S., Taghizadeh, N. R., Tannenbaum, S. R., Marinus, M. G., and Engelward, B. P. (2001) J. Bacteriol. 183, 131–138[Abstract/Free Full Text]
  27. Frankel, A. D., Duncan, B. K., and Hartman, P. E. (1980) J. Bacteriol. 142, 335–338[Medline] [Order article via Infotrieve]
  28. Sidorkina, O., Saparbaev, M., and Laval, J. (1997) Mutagenesis 12, 23–28[Abstract]
  29. Friedberg, E. C., Walker, G. C., and Siede, W. (1995) DNA Repair and Mutagenesis, AMS Press, Washington, D. C.
  30. Petit, C., and Sancar, A. (1999) Biochimie (Paris) 81, 15–25[CrossRef][Medline] [Order article via Infotrieve]
  31. Minko, I. G., Zou, Y., and Lloyd, R. S. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 1905–1909[Abstract/Free Full Text]
  32. Asagoshi, K., Yamada, T., Terato, H., Ohyama, Y., Monden, Y., Arai, T., Nishimura, S., Aburatani, H., Lindahl, T., and Ide, H. (2000) J. Biol. Chem. 275, 4956–4964[Abstract/Free Full Text]
  33. Asagoshi, K., Odawara, H., Nakano, H., Miyano, T., Terato, H., Ohyama, Y., Seki, S., and Ide, H. (2000) Biochemistry 39, 11389–11398[CrossRef][Medline] [Order article via Infotrieve]
  34. Asagoshi, K., Yamada, T., Okada, Y., Terato, H., Ohyama, Y., Seki, S., and Ide, H. (2000) J. Biol. Chem. 275, 24781–24786[Abstract/Free Full Text]
  35. Masaoka, A., Terato, H., Kobayashi, M., Honsho, A., Ohyama, Y., and Ide, H. (1999) J. Biol. Chem. 274, 25136–25143[Abstract/Free Full Text]
  36. Terato, H., Masaoka, A., Kobayashi, M., Fukushima, S., Ohyama, Y., Yoshida, M., and Ide, H. (1999) J. Biol. Chem. 274, 25144–25150[Abstract/Free Full Text]
  37. Roy, R., Biswas, T., Hazra, T. K., Roy, G., Grabowski, D. T., Izumi, T., Srinivasan, G., and Mitra, S. (1998) Biochemistry 37, 580–589[CrossRef][Medline] [Order article via Infotrieve]
  38. Ikeda, S., Biswas, T., Roy, R., Izumi, T., Boldogh, I., Kurosky, A., Sarker, A. H., Seki, S., and Mitra, S. (1998) J. Biol. Chem. 273, 21585–21593[Abstract/Free Full Text]
  39. Monden, Y., Arai, T., Asano, M., Ohtsuka, E., Aburatani, H., and Nishimura, S. (1999) Biochem. Biophys. Res. Commun. 258, 605–610[CrossRef][Medline] [Order article via Infotrieve]
  40. Kornberg, R. D., and Thomas, J. O. (1974) Science 184, 865–868[Medline] [Order article via Infotrieve]
  41. Kornberg, R. D. (1974) Science 184, 868–871[Medline] [Order article via Infotrieve]
  42. Kuznetsov, S. V., Sidorkina, O. M., Laval, J., and Ansari, A. (2001) Biochem. Biophys. Res. Commun. 288, 121–128[CrossRef][Medline] [Order article via Infotrieve]
  43. Aburatani, H., Hippo, Y., Ishida, T., Takashima, R., Matsuba, C., Kodama, T., Takao, M., Yasui, A., Yamamoto, K., and Asano, M. (1997) Cancer Res. 57, 2151–2156[Abstract]
  44. Nishioka, K., Ohtsubo, T., Oda, H., Fujiwara, T., Kang, D., Sugimachi, K., and Nakabeppu, Y. (1999) Mol. Biol. Cell 10, 1637–1652[Abstract/Free Full Text]
  45. Krokan, H. E., Otterlei, M., Nilsen, H., Kavli, B., Skorpen, F., Andersen, S., Skjelbred, C., Akbari, M., Aas, P. A., and Slupphaug, G. (2001) Prog. Nucleic Acids Res. Mol. Biol. 68, 365–386[Medline] [Order article via Infotrieve]
  46. Saparbaev, M., and Laval, J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5873–5877[Abstract]
  47. Terato, H., Masaoka, A., Asagoshi, K., Honsho, A., Ohyama, Y., Suzuki, T., Yamada, M., Makino, K., Yamamoto, K., and Ide, H. (2002) Nucleic Acids Res. 30, 4975–4984[Abstract/Free Full Text]
  48. Eritja, R., Horowitz, D. M., Walker, P. A., Ziehler-Martin, J. P., Boosalis, M. S., Goodman, M. F., Itakura, K., and Kaplan, B. E. (1986) Nucleic Acids Res. 14, 8135–8153[Abstract]
  49. Kamiya, H., Shimizu, M., Suzuki, M., Inoue, H., and Ohtsuka, E. (1992) Nucleosides Nucleotides 11, 247–260
  50. Mattagajasingh, S. N., and Misra, H. P. (1996) J. Biol. Chem. 271, 33550–33560[Abstract/Free Full Text]
  51. Kurtz, A. J., and Lloyd, R. S. (2003) J. Biol. Chem. 278, 5970–5976[Abstract/Free Full Text]
  52. Kunkel, T. A., and Bebenek, K. (2000) Annu. Rev. Biochem. 69, 497–529[CrossRef][Medline] [Order article via Infotrieve]
  53. Permana, P. M., and Snapka, R. M. (1994) Carcinogenesis 15, 1031–1036[Abstract]
  54. Winterbourn, C. C., and Kettle, A. J. (2000) Free Radic. Biol. Med. 29, 403–409[CrossRef][Medline] [Order article via Infotrieve]
  55. Kulcharyk, P. A., and Heinecke, J. W. (2001) Biochemistry 40, 3648–3656[CrossRef][Medline] [Order article via Infotrieve]
  56. Bruner, S. D., Norman, D. P., and Verdine, G. L. (2000) Nature 403, 859–866[CrossRef][Medline] [Order article via Infotrieve]
  57. Gilboa, R., Zharkov, D. O., Golan, G., Fernandes, A. S., Gerchman, S. E., Matz, E., Kycia, J. H., Grollman, A. P., and Shoham, G. (2002) J. Biol. Chem. 277, 19811–19816[Abstract/Free Full Text]
  58. Hollis, T., Ichikawa, Y., and Ellenberger, T. (2000) EMBO J. 19, 758–766[Abstract/Free Full Text]
  59. Zharkov, D. O., Golan, G., Gilboa, R., Fernandes, A. S., Gerchman, S. E., Kycia, J. H., Rieger, R. A., Grollman, A. P., and Shoham, G. (2002) EMBO J. 21, 789–800[Abstract/Free Full Text]
  60. Hazra, T. K., Izumi, T., Venkataraman, R., Kow, Y. W., Dizdaroglu, M., and Mitra, S. (2000) J. Biol. Chem. 275, 27762–27767[Abstract/Free Full Text]
  61. Roy, R., Kennel, S. J., and Mitra, S. (1996) Carcinogenesis 17, 2177–2182[Abstract]
  62. Hashimoto, M., Greenberg, M. M., Kow, Y. W., Hwang, J. T., and Cunningham, R. P. (2001) J. Am. Chem. Soc. 123, 3161–3162[CrossRef][Medline] [Order article via Infotrieve]
  63. Kroeger, K. M., Hashimoto, M., Kow, Y. W., and Greenberg, M. M. (2003) Biochemistry 42, 2449–2455[CrossRef][Medline] [Order article via Infotrieve]
  64. DeMott, M. S., Beyret, E., Wong, D., Bales, B. C., Hwang, J. T., Greenberg, M. M., and Demple, B. (2002) J. Biol. Chem. 277, 7637–7640[Abstract/Free Full Text]
  65. Xu, Y. J., DeMott, M. S., Hwang, J. T., Greenberg, M. M., and Demple, B. (2003) DNA Repair (Amst.) 2, 175–185[CrossRef][Medline] [Order article via Infotrieve]
  66. Van Houten B., Illenye, S., Qu, Y., and Farrell, N. (1993) Biochemistry 32, 11794–11801[Medline] [Order article via Infotrieve]